Clinical trial Recruiting at 1 site Interventional Ages 21 and up

SMILE with VISUMAX 500 versus VISUMAX 800 for correcting short-sightedness

Official title: Comparison of Myopic Small Incision Lenticule Extraction (SMILE) With VISUMAX 500 Versus VISUMAX 800 Platforms

Run by Singapore Eye Research Institute · NCT07505264 · Data updated 2026-11-12

We will try SMILE eye surgery with the newer VISUMAX 800 on one eye and the VISUMAX 500 on the other to see which gives better vision and recovery for people with myopia.

More Myopia trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment100 (estimated)
SponsorSingapore Eye Research Institute
Academic / other
Locations1 site (Singapore)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedMay 2027
Study endsJune 2027
Registry record updatedApril 1, 2026
Trial IDNCT07505264 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with stable mild-to-moderate myopia who meet SMILE eligibility (healthy corneas, refractive cylinder within limits, good corrected vision, and stable refractions) and who are candidates for bilateral SMILE are ideal.

Probably not a fit

People with progressive or unstable myopia/astigmatism, corneal ectasia or keratoconus, prior corneal surgery in the flap zone, significant ocular disease, or those outside the refractive limits are unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized contralateral-eye study will enroll 100 patients undergoing bilateral SMILE, with one eye randomized to the VisuMax 500 platform and the fellow eye to the VisuMax 800. The VisuMax 800 incorporates technical upgrades (2 MHz laser frequency, CentraLign centration guidance, OcuLign cyclotorsion compensation, separate laser and microscope arms, and heads-up docking) that could affect surgical precision and patient experience. Outcomes will include objective visual and refractive measures, corneal biomechanical and molecular markers, and patient-reported symptoms and satisfaction over postoperative follow-up. The design allows direct head-to-head comparison within the same patient to minimize intersubject variability.

Why it matters

Potential benefit: If the VISUMAX 800 performs better, patients could get equal or improved vision with potentially greater procedural precision, comfort, or faster recovery.

How similar studies have gone: Early non-randomized reports show VisuMax 800 outcomes comparable to VisuMax 500, but direct randomized head-to-head comparisons across multiple measures are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Cycloplegic spherical equivalent of \>-1.00D
* Refractive cylinder -2.00 D or less; anisometropia \<1.00D
* Best spectacle corrected visual acuity (BSCVA) of 6/12 or better in both eyes
* Spherical or cylindrical error has progressed at -0.50 D or less per year from date of baseline measurement in both eyes
* Contact lens wearers must have removed contact lenses at least 2 weeks before the baseline measurement
* No evidence of irregular astigmatism on corneal topography in both eyes

Exclusion Criteria:

* Progressive or unstable myopia and/or astigmatism
* Clinical or corneal topographic evidence of keratoconus
* Residual, recurrent or active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract, and retinal disease
* Previous corneal surgery or trauma within the corneal flap zone
* Patent corneal vascularization within 1 mm of the corneal flap zone
* Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites
* Systemically immunocompromised or systemic disease likely to affect wound healing, such as diabetes, connective tissue disease, and severe atopy; pregnant or nursing

Where it's running

  • Singapore National Eye Centre (SNEC)
    Singapore, Singapore
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.